Skip to main content
· 6/27/2014

Yanise Germain v. Teva Pharmaceuticals, USA, Inc

Citations

  • 756 F.3d 917
  • 2014 WL 2959271
  • 2014 U.S. App. LEXIS 12111

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • noting that under the Erie Doctrine, federal courts sitting in diversity are “bound by the rulings of the state supreme court”
  • explaining that the FDA can only approve a drug when it determines the drug is “safe for use” as prescribed in the “proposed labeling thereof”
  • finding that a plaintiff’s failure to update warnings claim to be “pure conjecture” because it was based solely on his beliefs
  • holding negligence claims preempted under Buckman where “the conduct that [p]laintiffs allege gives rise to their statutory negligence claims is the [defendants’] violation of the FDCA.”
  • explaining that parties forfeit issues that they do not properly raise on appeal
  • explaining that parties forfeit issues that they do not properly raise on appeal

Source: CourtListener parenthetical corpus (CC0).

Judges: Suhrheinrich, Rogers, Sutton

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.